In partnership with
Unmatched Quality. Proven Results. Momentous Creatine.
Creatine is one of the most effective and well-researched supplements for improving strength, power, recovery, and cognitive performance. Momentous Creatine contains Creapure®—the purest, pharmaceutical-grade creatine monohydrate—single-sourced from Germany for unmatched quality and consistency. Every batch is NSF Certified for Sport®, meaning it’s independently tested for safety, label accuracy, and banned substances.
With no fillers, no artificial additives, and clinically validated dosing, it embodies The Momentous Standard™—a commitment to science-backed formulas, transparency, and uncompromising quality. This is why it’s trusted by professional teams, Olympic athletes, and the U.S. military’s top performers.
Whether you’re starting your creatine journey or returning after a break, Momentous Creatine gives you the confidence of knowing you’re fueling your body with the very best—precisely formulated for results you can feel and trust.
Head to livemomentous.com and use code HIVE for up to 35% off your first order.
New to LEVITY? Start here! Want to know more about who’s behind LEVITY? Check out this page. 🙏🏼 Not subscribed to the LEVITY podcast on Youtube yet? Do it here. 🎧 More of a listener? The podcast is also available on Spotify, Apple Podcasts and other places.
Multi-agent AI research lab makes longevity breakthrough on first try
When Dario Amodei, CEO of Anthropic, wrote his much-discussed essay Machines of Loving Grace, he imagined “a country of geniuses in a datacenter.”
“The right way to think of AI is not as a method of data analysis, but as a virtual biologist who performs all the tasks biologists do, including designing and running experiments in the real world […] inventing new biological methods or measurement techniques, and so on. It is by speeding up the whole research process that AI can truly accelerate biology.”
That essay came out just a year ago. The vision hasn’t been fully realized, but we’re getting closer.
One of the best examples of this is a new multi-agent AI research system, K-Dense Beta, from Houston-based startup Biostate AI.
“We have created an AI scientist that can work 24/7, dramatically accelerating discovery while maintaining rigorous scientific standards”, said Ashwin Gopinath, co-founder and CEO of Biostate AI, in a press release.
While Gopinath uses the term “AI scientist,” K-Dense operates more like a full research lab. The system coordinates specialized agents that plan experiments, review literature, design analyses and generate publication-ready reports, according to Biostate.
There are also claims of having eliminated hallucinations “by operating like a team of independent scientific reviewers, with agents cross-checking references against external databases, adding feedback loops to improve accuracy.”
Together with Harvard’s David Sinclair, Biostate has now used K-Dense to make what they describe as a longevity breakthrough, set to be published in a peer-reviewed journal (a preprint is available here).
“K-Dense enabled us to complete an entire research study in just a few weeks, work that typically requires months or years of expert analysis.”
Biostate and Sinclair’s lab turned K-Dense onto one of the most critical instruments in aging research: the biological age clock. These are models built from molecular data - methylation marks, proteins, or gene expression - that estimate how fast our bodies are aging compared to our chronological years. Clocks are now central to geroscience, used to test whether interventions truly slow or reverse biological aging. Yet no single version has been universally accepted.
K-Dense uncovered evidence that different sets of genes dominate at different life stages. The RNA transcripts that signal biological age in a 30-year-old are not the same ones that matter in a 70-year-old. In other words, aging appears to move through shifting biological phases, with molecular priorities changing as we grow older.
Equally important, the clock produced by K-Dense does something its predecessors never did: it reports not only an age estimate but also how certain it is about that estimate. The researchers showed that uncertainty spikes precisely at moments when biology itself is in flux - adolescence, midlife transitions, and extreme old age. That means the clock doesn’t just measure age; it also highlights the turbulent passages when human biology is least stable.
For longevity research, this could matter a great deal. If aging is not one continuous process but a sequence of shifting programs, then interventions may need to be timed differently, tailored to the stage of life rather than applied indiscriminately. And if clocks can flag when they are most or least reliable, they become far more trustworthy as tools.
As you might expect, all of this was achieved with remarkable speed.
“K-Dense enabled us to complete an entire research study in just a few weeks, work that typically requires months or years of expert analysis,” said David Sinclair in the same press release. “It pointed us to markers and pathways that warrant deeper study and helped us build a unified AI model for predicting biological age. Importantly, it also provided a measure of how reliable those predictions are, which is critical for scientific applications and has not been available in prior AI approaches.”
This is, in a sense, the future Amodei sketched - some of his imagined “geniuses” now hard at work. It might not surprise you to learn that Amodei is an investor in Biostate.
